Abstract: The present invention relates to the display of antigenic or allergenic components along with a tissue-targeting component on viruses or virus-like particles. Capsid protein genes are recombinantly modified to contain the specified components then expressed within a host organism, such as yeasts, bacteria, or algae, and allowed to spontaneously form active virus particles or virus-like particles. The recombinant complexes (virus or virus-like particle) can then be purified or used in situ as a therapeutic tool for disease or allergy prevention. The expression of multivalent and multifunctional components to increase the immunogenicity of the recombinant complexes, especially on oral administration, is provided.

Abstract: Anaerobic bacteria are incorporated in a feed such that they provide a benefit to the consuming animal. Anaerobic bacteria can be viable and colonize the gut to provide this benefit by displacing harmful bacteria, secreting a particular agent (e.g., enzyme, antibiotic or bioactive compound), binding or sequestering harmful organisms or compounds, or providing a beneficial physical effect. Anaerobic bacteria can also be added n a non-viable form wherein the added bacteria provide a benefit to the consuming organism by delivering preformed compounds such as enzymes, bioactive agents, or polymers. Recombinant anaerobes can be utilized for any of the above purposes. Feeds can contain naked bacteria, spores, treated bacteria such as encapsulated, coated or freeze dried bacteria, in order to maintain either viability or stability of the active function.